These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24837431)

  • 61. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
    Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
    Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mammalian target of rapamycin complex I (mTORC1) activity in ras homologue enriched in brain (Rheb)-deficient mouse embryonic fibroblasts.
    Groenewoud MJ; Goorden SM; Kassies J; Pellis-van Berkel W; Lamb RF; Elgersma Y; Zwartkruis FJ
    PLoS One; 2013; 8(11):e81649. PubMed ID: 24303063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.
    Arif A; Terenzi F; Potdar AA; Jia J; Sacks J; China A; Halawani D; Vasu K; Li X; Brown JM; Chen J; Kozma SC; Thomas G; Fox PL
    Nature; 2017 Feb; 542(7641):357-361. PubMed ID: 28178239
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The long noncoding RNA MEG3 regulates Ras-MAPK pathway through RASA1 in trophoblast and is associated with unexplained recurrent spontaneous abortion.
    Zhang J; Liu X; Gao Y
    Mol Med; 2021 Jul; 27(1):70. PubMed ID: 34238211
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1.
    Norden PR; Kim DJ; Barry DM; Cleaver OB; Davis GE
    PLoS One; 2016; 11(1):e0147758. PubMed ID: 26812085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.
    Burrows PE; Gonzalez-Garay ML; Rasmussen JC; Aldrich MB; Guilliod R; Maus EA; Fife CE; Kwon S; Lapinski PE; King PD; Sevick-Muraca EM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8621-6. PubMed ID: 23650393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA‑21 regulates the biological behavior of esophageal squamous cell carcinoma by targeting RASA1.
    Chen X; Cai S; Li B; Zhang X; Li W; Liang H; Cao X; Wang L; Wu Z
    Oncol Rep; 2019 Mar; 41(3):1627-1637. PubMed ID: 30569149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules.
    Guichard SM; Curwen J; Bihani T; D'Cruz CM; Yates JW; Grondine M; Howard Z; Davies BR; Bigley G; Klinowska T; Pike KG; Pass M; Chresta CM; Polanska UM; McEwen R; Delpuech O; Green S; Cosulich SC
    Mol Cancer Ther; 2015 Nov; 14(11):2508-18. PubMed ID: 26358751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
    EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels.
    James MH; Quinn RK; Ong LK; Levi EM; Charnley JL; Smith DW; Dickson PW; Dayas CV
    Neuropsychopharmacology; 2014 Jun; 39(7):1694-702. PubMed ID: 24469593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RASA1-driven cellular export of collagen IV is required for the development of lymphovenous and venous valves in mice.
    Chen D; Geng X; Lapinski PE; Davis MJ; Srinivasan RS; King PD
    Development; 2020 Dec; 147(23):. PubMed ID: 33144395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of Proteins That Rapidly Change Upon Mechanistic/Mammalian Target of Rapamycin Complex 1 (mTORC1) Repression Identifies Parkinson Protein 7 (PARK7) as a Novel Protein Aberrantly Expressed in Tuberous Sclerosis Complex (TSC).
    Niere F; Namjoshi S; Song E; Dilly GA; Schoenhard G; Zemelman BV; Mechref Y; Raab-Graham KF
    Mol Cell Proteomics; 2016 Feb; 15(2):426-44. PubMed ID: 26419955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
    Davies MH; Stempel AJ; Hubert KE; Powers MR
    Dev Dyn; 2010 Jun; 239(6):1695-707. PubMed ID: 20503366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
    Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
    Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
    Cao J; Huang W
    PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation.
    Revencu N; Boon LM; Mendola A; Cordisco MR; Dubois J; Clapuyt P; Hammer F; Amor DJ; Irvine AD; Baselga E; Dompmartin A; Syed S; Martin-Santiago A; Ades L; Collins F; Smith J; Sandaradura S; Barrio VR; Burrows PE; Blei F; Cozzolino M; Brunetti-Pierri N; Vicente A; Abramowicz M; Désir J; Vilain C; Chung WK; Wilson A; Gardiner CA; Dwight Y; Lord DJ; Fishman L; Cytrynbaum C; Chamlin S; Ghali F; Gilaberte Y; Joss S; Boente Mdel C; Léauté-Labrèze C; Delrue MA; Bayliss S; Martorell L; González-Enseñat MA; Mazereeuw-Hautier J; O'Donnell B; Bessis D; Pyeritz RE; Salhi A; Tan OT; Wargon O; Mulliken JB; Vikkula M
    Hum Mutat; 2013 Dec; 34(12):1632-41. PubMed ID: 24038909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.
    Dai Q; Xie F; Han Y; Ma X; Zhou S; Jiang L; Zou W; Wang J
    J Biol Chem; 2017 Jan; 292(1):196-204. PubMed ID: 27879318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.